User profiles for Carles Foguet
Carles FoguetUniversity of Cambridge Verified email at medschl.cam.ac.uk Cited by 320 |
An atlas of genetic scores to predict multi-omic traits
…, SA Lambert, UA Tahir, S May-Wilson, C Foguet… - Nature, 2023 - nature.com
The use of omic modalities to dissect the molecular underpinnings of common diseases and
traits is becoming increasingly common. But multi-omic traits can be genetically predicted, …
traits is becoming increasingly common. But multi-omic traits can be genetically predicted, …
PhenoMeNal: processing and analysis of metabolomics data in the cloud
Background Metabolomics is the comprehensive study of a multitude of small molecules to
gain insight into an organism's metabolism. The research field is dynamic and expanding …
gain insight into an organism's metabolism. The research field is dynamic and expanding …
[HTML][HTML] Genetically personalised organ-specific metabolic models in health and disease
Understanding how genetic variants influence disease risk and complex traits (variant-to-function)
is one of the major challenges in human genetics. Here we present a model-driven …
is one of the major challenges in human genetics. Here we present a model-driven …
[HTML][HTML] Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity
…, S Sánchez-García, C Foguet… - Frontiers in …, 2023 - frontiersin.org
In recent years, the central role of cell bioenergetics in regulating immune cell function and
fate has been recognized, giving rise to the interest in immunometabolism, an area of …
fate has been recognized, giving rise to the interest in immunometabolism, an area of …
An assessment of quaternary structure functionality in homomer protein complexes
G Abrusán, C Foguet - Molecular Biology and Evolution, 2023 - academic.oup.com
It has been recently suggested that a significant fraction of homomer protein–protein interfaces
evolve neutrally, without contributing to function, due to a hydrophobic bias in missense …
evolve neutrally, without contributing to function, due to a hydrophobic bias in missense …
[HTML][HTML] The landscape of tiered regulation of breast cancer cell metabolism
Altered metabolism is a hallmark of cancer, but little is still known about its regulation. In this
study, we measure transcriptomic, proteomic, phospho-proteomic and fluxomics data in a …
study, we measure transcriptomic, proteomic, phospho-proteomic and fluxomics data in a …
[HTML][HTML] A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer …
…, C Fernández-Martos, E Elez, C Foguet… - Cancer Immunology …, 2023 - Springer
Background Immune check-point blockade (ICB) has shown clinical benefit in mismatch
repair-deficient/microsatellite instability high metastatic colorectal cancer (mCRC) but not in …
repair-deficient/microsatellite instability high metastatic colorectal cancer (mCRC) but not in …
Interoperable and scalable data analysis with microservices: applications in metabolomics
Motivation Developing a robust and performant data analysis workflow that integrates all
necessary components whilst still being able to scale over multiple compute nodes is a …
necessary components whilst still being able to scale over multiple compute nodes is a …
[HTML][HTML] Genome scale modeling to study the metabolic competition between cells in the tumor microenvironment
Simple Summary Immune and cancer cells compete for nutrients within the tumor
microenvironment, leading to a metabolic battle between these cell populations. In this battle, tumor …
microenvironment, leading to a metabolic battle between these cell populations. In this battle, tumor …
[HTML][HTML] Cysteine and folate metabolism are targetable vulnerabilities of metastatic colorectal cancer
Simple Summary In this work, we studied the metabolic reprogramming of same-patient-derived
cell lines with increasing metastatic potential to develop new therapeutic approaches …
cell lines with increasing metastatic potential to develop new therapeutic approaches …